The ADC Cytotoxic Payloads / Warheads market is anticipated to grow at a CAGR of 12.4% till 2030, claims Roots Analysis

With six approved drugs, namely POLIVY™, LUMOXITI™, BESPONSA®, MYLOTARG™, KADCYLA®, ADCETRIS® and over 300 drugs underdevelopment, antibody drug conjugates (ADCs) have emerged as a promising class of targeted therapies for various disease indications.

For additional details, please visit

comments (0)

22 more from jameshebrew